Dlg1 — Discs Large Homolog 1 Protein (Maguk Scaffold) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
...
DLG1 — Discs Large Homolog 1 Protein (MAGUK Scaffold)
Dlg1 — Discs Large Homolog 1 Protein (Maguk Scaffold) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
DLG1 (Discs Large Homolog 1) is a member of the membrane-associated guanylate kinase (MAGUK) family of scaffold proteins. It is a core component of the postsynaptic density, organizing glutamate receptors and signaling molecules at excitatory synapses. [@ref2015]
Altered synaptic scaffolding in dopaminergic [neurons](/entities/neurons)
Autism Spectrum Disorder
DLG1 mutations cause ASD
Disrupted synaptic organization
Cancer
Tumor suppressor function
Cell polarity defects
Therapeutic Targeting
Expression Pattern
DLG1 exhibits widespread expression throughout the brain with highest levels in the cerebral [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and cerebellum. In the mouse brain, Dlg1 is expressed in excitatory pyramidal neurons of layers 2/3 and 5, as well as in inhibitory interneurons. The protein localizes primarily to the postsynaptic density of excitatory (glutamatergic) synapses, where it forms a core scaffold alongside PSD-95 (DLG4). Expression is developmentally regulated, with increasing levels during the first three weeks of postnatal development corresponding to synaptogenesis. In human brain tissue, DLG1 protein is detected in all cortical layers, with particularly strong expression in the [entorhinal cortex](/brain-regions/entorhinal-cortex) and CA1 region of hippocampus — areas vulnerable in Alzheimer's disease.
Molecular Mechanisms
DLG1 functions as a master scaffold at excitatory synapses through its multi-domain architecture. The three PDZ domains (PDZ1-3) bind to the C-termini of various receptors and channels:
NMDA receptors (via GluN2A/B subunits)
AMPA receptors (via stargazin/γ-2)
K+ channels (Kv1.x family)
neuroligins and neurexins
The SH3 domain interacts with proline-rich motifs in signaling proteins including RAF kinases and p140Cap, while the GUK domain, though catalytically inactive, provides additional protein-protein interaction surfaces. DLG1 also participates in the PI3K-Akt signaling pathway by scaffolding Akt and its upstream activators. At [dendritic spines](/cell-types/dendritic-spines), DLG1 recruitment is activity-dependent — NMDA receptor activation triggers Ca2+ influx, activating CaMKII, which phosphorylates DLG1 and enhances its synaptic retention.
Research Directions
Recent research focuses on understanding DLG1 dysfunction in neurodegenerative diseases. Studies examine:
How [Aβ](/proteins/amyloid-beta) oligomers disrupt DLG1-synaptic targeting
DLG1 phosphorylation patterns in AD brain vs. healthy controls
Post-mortem studies of DLG1 expression in prefrontal cortex of AD patients
Development of cell-permeable peptides that stabilize DLG1 interactions
AAV-mediated DLG1 overexpression in mouse models of synaptic dysfunction
Background
The study of Dlg1 — Discs Large Homolog 1 Protein (Maguk Scaffold) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.